Russ C - Search Results

1

Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States.

Baker CL, Dhamane AD, Mardekian J, Dina O, Russ C, Rosenblatt L, Lingohr-Smith M, Menges B, Lin J, Nadkarni A. Baker CL, et al. Among authors: russ c. Adv Ther. 2019 Jan;36(1):162-174. doi: 10.1007/s12325-018-0840-8. Epub 2018 Nov 29. Adv Ther. 2019. PMID: 30499067 Free PMC article.

2

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.

Amin A, Keshishian A, Dina O, Dhamane A, Nadkarni A, Carda E, Russ C, Rosenblatt L, Mardekian J, Yuce H, Baker CL. Amin A, et al. Among authors: russ c. J Thromb Thrombolysis. 2019 Aug;48(2):240-249. doi: 10.1007/s11239-019-01838-5. J Thromb Thrombolysis. 2019. PMID: 30924051 Free PMC article.

3

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients.

Dhamane AD, Baker CL, Rajpura J, Mardekian J, Dina O, Russ C, Rosenblatt L, Lingohr-Smith M, Lin J. Dhamane AD, et al. Among authors: russ c. Curr Med Res Opin. 2019 Oct;35(10):1769-1776. doi: 10.1080/03007995.2019.1623187. Epub 2019 Jun 5. Curr Med Res Opin. 2019. PMID: 31120309

4

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants.

Baker CL, Dhamane AD, Rajpura J, Mardekian J, Dina O, Russ C, Rosenblatt L, Lingohr-Smith M, Lin J. Baker CL, et al. Among authors: russ c. Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619870249. doi: 10.1177/1076029619870249. Clin Appl Thromb Hemost. 2019. PMID: 31418293 Free PMC article.

5

Comparison of inpatient admission rates of patients treated with apixaban vs. warfarin for venous thromboembolism in the emergency department.

Deitelzweig S, Hlavacek P, Mardekian J, Rosenblatt L, Russ C, Tuell K, Lingohr-Smith M, Lin J, Guo JD. Deitelzweig S, et al. Among authors: russ c. Hosp Pract (1995). 2020 Feb;48(1):41-48. doi: 10.1080/21548331.2020.1718925. Epub 2020 Feb 6. Hosp Pract (1995). 2020. PMID: 31976776

6

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States.

Deitelzweig S, Baker CL, Dhamane AD, Mardekian J, Dina O, Rosenblatt L, Russ C, Poretta T, Lingohr-Smith M, Lin J. Deitelzweig S, et al. Among authors: russ c. J Drug Assess. 2020 Apr 24;9(1):87-96. doi: 10.1080/21556660.2020.1750418. eCollection 2020. J Drug Assess. 2020. PMID: 32489717 Free PMC article.

7

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA.

Deitelzweig S, Dhamane AD, Di Fusco M, Russ C, Rosenblatt L, Lingohr-Smith M, Lin J. Deitelzweig S, et al. Among authors: russ c. J Med Econ. 2020 Dec;23(12):1389-1400. doi: 10.1080/13696998.2020.1832099. Epub 2020 Oct 19. J Med Econ. 2020. PMID: 33021129 Free article.

8

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA.

Dhamane AD, Hernandez I, Di Fusco M, Gutierrez C, Ferri M, Russ C, Tsai WL, Emir B, Yuce H, Keshishian A. Dhamane AD, et al. Among authors: russ c. Am J Cardiovasc Drugs. 2022 May;22(3):333-343. doi: 10.1007/s40256-021-00501-w. Epub 2021 Oct 21. Am J Cardiovasc Drugs. 2022. PMID: 34671944 Free PMC article.

9

Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.

Lip GYH, Murphy RR, Sahiar F, Ingall TJ, Dhamane AD, Ferri M, Hlavacek P, Preib MT, Keshishian A, Russ C, Rosenblatt L, Yuce H, Deitelzweig S. Lip GYH, et al. Among authors: russ c. JAMA Netw Open. 2022 Aug 1;5(8):e2229333. doi: 10.1001/jamanetworkopen.2022.29333. JAMA Netw Open. 2022. PMID: 36044214 Free PMC article.

10

Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population.

Hlavacek P, Guo JD, Rosenblatt L, Keshishian A, Russ C, Mardekian J, Ferri M, Poretta T, Yuce H, McBane R. Hlavacek P, et al. Among authors: russ c. Curr Med Res Opin. 2019 Dec;35(12):2043-2051. doi: 10.1080/03007995.2019.1653067. Epub 2019 Sep 3. Curr Med Res Opin. 2019. PMID: 31387467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

253 results

Search Page